Ticker · CUSIP 002120202

ATYR

ATYR PHARMA INC
···Share
Holders (tracked)
5
Combined shares
1,651,389
Combined value
$1.26M
Last close
Quarter
2025Q4
Tracked holders · last 8 quarters
-2 vs previous quarter over the last 8.
572024Q12025Q4

SEC event timeline

13 events
  1. −458,000 shares · 2025Q4
    13F
  2. −83,312 shares · 2025Q4
    13F
  3. +243,443 shares · 2025Q4
    13F
  4. −1,890,921 shares · 2025Q4
    13F
  5. −289,231 shares · 2025Q4
    13F
  6. +769,820 shares · 2025Q4
    13F
  7. +2,601 shares · 2025Q3
    13F
  8. −988,677 shares · 2025Q3
    13F
  9. +179,672 shares · 2025Q3
    13F
  10. +74,303 shares · 2025Q3
    13F
  11. +290,721 shares · 2025Q3
    13F
  12. +68,026 shares · 2025Q3
    13F
  13. −518,355 shares · 2025Q3
    13F

Insider activity

No insider transactions in the last 30 days.

Who moved on this name in 2025Q4

13F transactions reported for the latest quarter, grouped by direction.
New positions1
Added to1
Trimmed1
Exited3

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2022Q1
7
$4.6M
2022Q2
5
$1.8M
2022Q3
4
$2K
2022Q4
7
$1.0M
2023Q1
6
$1.1M
2023Q2
7
$5.4M
2023Q3
7
$5.3M
2023Q4
7
$4.6M
2024Q1
7
$6.5M
2024Q2
6
$7.2M
2024Q3
5
$3.9M
2024Q4
7
$21.4M
2025Q1
8
$16.6M
2025Q2
11
$19.7M
2025Q3
7
$2.4M
2025Q4
5
$1.3M

Who owns ATYR

5 super-investors · 2025Q4
Tracked stake
1.65M
shares
Combined value
$1M
% of shares outstanding
shares-out unknown
Quarter action mix
New1Added1Trim2Held1
#ManagerSharesValue
1AQR Capital Management769.8K$603K
2Two Sigma Investments454.4K$356K
3Ken Griffin
Citadel Advisors
253.8K$199K
4Ken Griffin
Citadel Advisors
127.2K$100K
5T. Rowe Price46.1K$36

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live ATYR chart.
<iframe src="https://openstocks.me/embed/stock/ATYR" width="100%" height="480" frameborder="0" loading="lazy" title="ATYR chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>